ZyVersa Therapeutics Inc [NASDAQ: ZVSA] stock went on an upward path that rose over 17.37% on Tuesday, amounting to a one-week price increase of more than 14.46%.
Over the last 12 months, ZVSA stock dropped by -26.89%. The one-year ZyVersa Therapeutics Inc stock forecast points to a potential upside of 96.15. The average equity rating for ZVSA stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $3.78 million, with 4.87 million shares outstanding and 4.86 million shares in the current float. Compared to the average trading volume of 4.09M shares, ZVSA stock reached a trading volume of 207259800 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on ZyVersa Therapeutics Inc [ZVSA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ZVSA shares is $20.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ZVSA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 0.24, with the Price to Cash per share for the same quarter was set at 0.33.
ZVSA Stock Performance Analysis:
ZyVersa Therapeutics Inc [ZVSA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 14.46. With this latest performance, ZVSA shares gained by 20.12% in over the last four-week period, additionally sinking by -28.90% over the last 6 months – not to mention a drop of -26.89% in the past year of trading.
Insight into ZyVersa Therapeutics Inc Fundamentals:
Return on Equity for this stock declined to -41.48%, with Return on Assets sitting at -41.48%.
ZyVersa Therapeutics Inc [ZVSA] Institutonal Ownership Details
There are presently around $7.28%, or 7.29% of ZVSA stock, in the hands of institutional investors.
